Vir Biotechnology VIR
NASDAQ VIR
$10.64 -0.01 (-0.14%)
As of: Sep 30, 2026 · 9:42 AM EDT

Vir Biotechnology (VIR) FCF Margin (2018 - 2026)

Updated

Vir Biotechnology (VIR) posted FCF Margin of 51.60% for Q2 2026, up 10163.38 percentage points from -10111.78% a year earlier and up 457899.87 percentage points from the prior quarter.

Analysis

Vir Biotechnology (VIR) FCF Margin (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Vir Biotechnology was -67.13%, up 2387.50 percentage points year-over-year; for FY2025, it came in at -578.52%, up 32.83 percentage points from FY2024.

  • Annual FCF Margin shows a five-year change of -319.92 percentage points (FY2020 to FY2025).
  • In prior years, Vir Biotechnology's FCF Margin was -611.35% in FY2024 (+317.35 pp), -928.71% in FY2023 (-1027.43 pp), 98.73% in FY2022 (+105.06 pp) and -6.34% in FY2021 (+252.27 pp).
  • The Q2 2026 figure stands as the highest quarterly FCF Margin since Q2 2022.
  • On a year-over-year basis, FCF Margin increased in two of the last eight quarters, with an average year-over-year change of -64792.78 percentage points.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q2 2026, with a gain of 10163.38 percentage points; the weakest was Q1 2026, with a drop of 455218.16 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was -457848.28% (Q1 2026), -40.93% (Q4 2025) and -69952.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Vir Biotechnology 1.78 Bn 1.78 Bn 238.95 Mn 51.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.60%
Mar 31, 2026 -457,848.28%
Dec 31, 2025 -40.93%
Sep 30, 2025 -69,952.92%
Jun 30, 2025 -10,111.78%
Mar 31, 2025 -2,630.11%
Dec 31, 2024 -724.34%
Sep 30, 2024 -7,321.34%
Jun 30, 2024 -2,553.27%
Mar 31, 2024 -197.36%
Dec 31, 2023 -652.06%
Sep 30, 2023 -6,045.59%
Jun 30, 2023 -10,500.50%
Mar 31, 2023 -210.70%
Dec 31, 2022 45.64%
Sep 30, 2022 26.41%
Jun 30, 2022 2,312.48%
Mar 31, 2022 43.35%
Dec 31, 2021 -0.66%
Sep 30, 2021 -107.92%
API Access

Vir Biotechnology FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY